-
-
Sunosi®▼ (solriamfetol) for EDS
-
Posted in Industry News
-
09th Nov 2021
-
NICE Issues Positive Guidance for Sunosi®▼ (solriamfetol) in Excessive Daytime Sleepiness
-
-
Young Epilepsy announces world-first technological breakthrough
-
Posted in Industry News
-
08th Nov 2021
-
News from Young Epilepsy
-
-
Back the #ABIBill
-
Posted in Industry News
-
05th Nov 2021
-
Support the Bill calling for a comprehensive strategy to meet the needs of adults and children with an acquired brain injury
-
-
WFNR celebrates 25th anniversary
-
Posted in Course & Conference Previews,Industry News
-
05th Nov 2021
-
“Congratulations to the WFNR for all that it has achieved over the last 25 years. Today the WFNR is a true advocate for neurorehabilitation” said Professor David Good, WFNR President as the organisation celebrates its 25th anniversary. He continued: “We’re extremely grateful to all our members who have contributed to the success of the organisation […]
-
-
New platform to speed discovery of biomarkers for neurodegenerative diseases
-
Posted in Industry News
-
02nd Nov 2021
-
New from the European Platform for Neurodegenerative Diseases (EPND)
-
-
Sudden cardiac death and atrial fibrillation: patient educational days
-
Posted in Industry News
-
01st Nov 2021
-
News of patient information days
-
-
New study designs investigating impact of ONGENTYS® (opicapone) on non-motor symptoms presented for first time at the MDS Virtual Congress 2021
-
Posted in Industry News
-
25th Sep 2021
-
News from Bial at the MDS congress
-
-
New support group for families affected by brain injury
-
Posted in Industry News
-
14th Sep 2021
-
New special interest group launched to support families of people with brain injury
-
-
Apomorphine Sublingual Film for PD
-
Posted in Industry News
-
14th Sep 2021
-
News from BIAL
-
-
Nerve Tumours UK
-
Posted in Industry News
-
22nd Aug 2021
-
News of the Neurofibromatosis Association